Last reviewed · How we verify
NCT06032429
Effects of Shared Medical Appointments for Diabetic Patients in Taiwan
NA trial testing Shared Medical Appointments in Diabetes Mellitus in 70 participants. Completed in 31 December 2020.
31 December 2020
Quick facts
| Lead sponsor | Dalin Tzu Chi General Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 70 |
| Start date | 1 February 2019 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Shared Medical Appointments
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Dalin Tzu Chi General Hospital
Who can join
Adults 45 to 80, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This quasi-experimental study is done to investigate the effect of Shared Medical Appointments (SMA) program for the diabetic patients in Taiwan. The relevant corresponding effects were determined via the generalized estimating equation (GEE) model.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06032429
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Shared Medical Appointments
Trials testing the same drug.
- NCT06923046 — Implementation of Team Clinic for Type 2 Diabetes (TCT2) · NA · recruiting
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other Dalin Tzu Chi General Hospital trials
Trials by the same sponsor.
- NCT07180485 — Effectiveness of Whole Body Vibration on Health Outcomes in Older Adults With Dynapenic Abdominal Obesity · NA · not yet recruiting
- NCT06963125 — The Effects of Prune Juice on Bowel Movement Patterns, Constipation Symptoms, and Quality of Life · NA · recruiting
- NCT06791980 — Integrated Care Approach for Rheumatoid Arthritis Patients · NA · completed
- NCT06344169 — Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section · Phase 2, PHASE3 · recruiting
- NCT06875115 — Evaluation of the Efficacy of Laser Acupuncture on Uremic Pruritus · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06032429 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dalin Tzu Chi General Hospital
- Last refreshed: 13 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06032429.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing